#Regulatory Affairs
Latest news articles tagged with "Regulatory Affairs". Follow the timeline of events, related topics, and entities.
Articles (4)
-
🇺🇸 Cantor Fitzgerald downgrades Replimune stock rating after second FDA rejection
[USA]
Related: #Biotechnology, #Financial Markets
-
🇺🇸 Leerink reiterates Rhythm Pharmaceuticals stock rating on CHMP opinion
[USA]
Related: #Pharmaceuticals, #Stock Market
-
🇺🇸 Compass Pathways at TD Cowen Conference: Promising Data for Depression Drug
[USA]
Related: #Pharmaceutical Innovation, #Mental Health Treatment, #Clinical Trials
-
🇺🇸 U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
[USA]
The F.D.A.’s refusal to examine the company’s mRNA shot drew widespread criticism from doctors and was divisive within the agency.
Related: #Public Health, #Medical Innovation
Key Entities (10)
- Leerink Partners (1 news)
- CHMP (1 news)
- Regulation (1 news)
- Phases of clinical research (1 news)
- Compass Pathways (1 news)
- Cantor Fitzgerald (1 news)
- Moderna (1 news)
- Rejection (1 news)
- Criticism (1 news)
- Food and Drug Administration (1 news)
About the topic: Regulatory Affairs
The topic "Regulatory Affairs" aggregates 4+ news articles from various countries.